1017779-71-3 Usage
Uses
Used in Pharmaceutical Synthesis:
4,5-Difluoro-2-Methoxyaniline is used as a key intermediate in the synthesis of pharmaceuticals, contributing to the development of new drugs due to its unique molecular structure and properties.
Used in Agricultural Chemical Production:
4,5-Difluoro-2-Methoxyaniline also serves as an intermediate in the production of agricultural chemicals, playing a role in the creation of effective and targeted pest control agents.
Used in Dye and Pigment Manufacturing:
4,5-Difluoro-2-Methoxyaniline is utilized as an intermediate in the organic synthesis of dyes and pigments, providing a foundation for the development of colorants with specific characteristics for various applications.
Used in Material Science:
4,5-Difluoro-2-Methoxyaniline has been studied for its potential applications in material science, where it may contribute to the advancement of new materials with specialized properties.
Used in Development of Functional Molecules:
4,5-Difluoro-2-Methoxyaniline is considered a building block for the development of new functional molecules, indicating its importance in the design and synthesis of innovative chemical entities.
Check Digit Verification of cas no
The CAS Registry Mumber 1017779-71-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,1,7,7,7 and 9 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1017779-71:
(9*1)+(8*0)+(7*1)+(6*7)+(5*7)+(4*7)+(3*9)+(2*7)+(1*1)=163
163 % 10 = 3
So 1017779-71-3 is a valid CAS Registry Number.
InChI:InChI=1/C7H7F2NO/c1-11-7-3-5(9)4(8)2-6(7)10/h2-3H,10H2,1H3
1017779-71-3Relevant academic research and scientific papers
FURTHER SUBSTITUTED TRIAZOLO QUINOXALINE DERIVATIVES
-
Paragraph 0440; 0443-0444, (2020/02/08)
The present invention relates to compounds according to general formula (I) which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.
